AGENUS INC Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AGENUS INC stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $55.00K.
- AGENUS INC stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $78.00K.
- AGENUS INC stock issued during period, value, employee stock purchase plan for the quarter ending 2023-09-30 was $410.00K.
- AGENUS INC stock issued during period, value, employee stock purchase plan for fiscal 2016 was $435.84K, a 109.26% increase from fiscal 2015.
- AGENUS INC stock issued during period, value, employee stock purchase plan for fiscal 2015 was $208.28K, a 95.39% increase from fiscal 2014.
- AGENUS INC stock issued during period, value, employee stock purchase plan for fiscal 2014 was $106.60K, a 19.93% increase from fiscal 2013.
- AGENUS INC stock issued during period, value, employee stock purchase plan for fiscal 2013 was $88.88K, a 70.29% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $55.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $78.00K 10-Q · filed 2025-11-10 | |
| 2023-09-30 | $410.00K 10-Q · filed 2024-11-12 | |
| 2016-12-31 | $435.84K 10-K · filed 2017-03-16 | |
| 2015-12-31 | $208.28K 10-K · filed 2017-03-16 | |
| 2014-12-31 | $106.60K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $88.88K 10-K · filed 2016-03-15 | |
| 2012-12-31 | $52.19K 10-K · filed 2015-03-16 | |
| 2011-12-31 | $81.10K 10-K · filed 2014-03-07 | |
| 2010-12-31 | $48.60K 10-K · filed 2013-03-18 | |
| 2009-12-31 | $16.93K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |